AxoGen Return on Tangible Equity 2010-2025 | AXGN
Current and historical return on tangible equity values for AxoGen (AXGN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| AxoGen Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.01B | $0.10B | -8.38% |
| 2024-12-31 | $-0.01B | $0.10B | -11.86% |
| 2024-09-30 | $-0.02B | $0.09B | -16.48% |
| 2024-06-30 | $-0.02B | $0.09B | -18.68% |
| 2024-03-31 | $-0.02B | $0.09B | -24.04% |
| 2023-12-31 | $-0.02B | $0.09B | -23.66% |
| 2023-09-30 | $-0.02B | $0.09B | -24.34% |
| 2023-06-30 | $-0.02B | $0.09B | -24.08% |
| 2023-03-31 | $-0.02B | $0.09B | -24.81% |
| 2022-12-31 | $-0.03B | $0.10B | -28.43% |
| 2022-09-30 | $-0.03B | $0.10B | -27.52% |
| 2022-06-30 | $-0.03B | $0.10B | -29.38% |
| 2022-03-31 | $-0.03B | $0.10B | -28.18% |
| 2021-12-31 | $-0.03B | $0.11B | -23.68% |
| 2021-09-30 | $-0.03B | $0.11B | -23.98% |
| 2021-06-30 | $-0.02B | $0.12B | -18.57% |
| 2021-03-31 | $-0.02B | $0.12B | -18.49% |
| 2020-12-31 | $-0.02B | $0.12B | -19.09% |
| 2020-09-30 | $-0.02B | $0.12B | -19.51% |
| 2020-06-30 | $-0.03B | $0.12B | -22.92% |
| 2020-03-31 | $-0.03B | $0.12B | -21.33% |
| 2019-12-31 | $-0.03B | $0.13B | -22.14% |
| 2019-09-30 | $-0.03B | $0.13B | -20.11% |
| 2019-06-30 | $-0.03B | $0.14B | -18.21% |
| 2019-03-31 | $-0.03B | $0.14B | -17.84% |
| 2018-12-31 | $-0.02B | $0.15B | -18.97% |
| 2018-09-30 | $-0.02B | $0.15B | -22.22% |
| 2018-06-30 | $-0.02B | $0.15B | -33.33% |
| 2018-03-31 | $-0.01B | $0.02B | -73.85% |
| 2017-12-31 | $-0.01B | $0.02B | -72.73% |
| 2017-09-30 | $-0.01B | $0.01B | -124.44% |
| 2017-06-30 | $-0.01B | $0.01B | -160.00% |
| 2017-03-31 | $-0.02B | $0.01B | -222.22% |
| 2016-12-31 | $-0.02B | $0.01B | -300.00% |
| 2016-09-30 | $-0.01B | $0.00B | -371.43% |
| 2016-06-30 | $-0.01B | $0.00B | -224.00% |
| 2016-03-31 | $-0.01B | $0.00B | -294.74% |
| 2015-12-31 | $-0.01B | $0.01B | -400.00% |
| 2015-09-30 | $-0.02B | $0.01B | 1066.67% |
| 2015-06-30 | $-0.02B | $0.00B | 228.57% |
| 2015-03-31 | $-0.02B | $0.00B | 212.50% |
| 2014-12-31 | $-0.02B | $-0.01B | 194.29% |
| 2014-09-30 | $-0.02B | $-0.01B | 260.87% |
| 2014-06-30 | $-0.02B | $-0.01B | 800.00% |
| 2014-03-31 | $-0.02B | $0.00B | 600.00% |
| 2013-12-31 | $-0.01B | $0.00B | 430.77% |
| 2013-09-30 | $-0.01B | $0.00B | 350.00% |
| 2013-06-30 | $-0.01B | $-0.01B | 240.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 500.00% |
| 2012-12-31 | $-0.01B | $0.00B | -1800.00% |
| 2012-09-30 | $-0.01B | $0.00B | -280.00% |
| 2012-06-30 | $-0.01B | $0.00B | -188.24% |
| 2012-03-31 | $-0.01B | $0.00B | -133.33% |
| 2011-12-31 | $-0.01B | $0.01B | -114.29% |
| 2011-09-30 | $-0.01B | $0.01B | -288.89% |
| 2011-06-30 | $-0.01B | $0.01B | -209.52% |
| 2011-03-31 | $-0.01B | $0.01B | -180.00% |
| 2010-12-31 | $-0.01B | $-0.01B | -120.00% |
| 2010-09-30 | $0.01B | $0.01B | 130.23% |
| 2010-06-30 | $0.02B | $0.01B | 181.82% |
| 2010-03-31 | $0.02B | $0.01B | 272.73% |
| 2009-12-31 | $0.02B | $0.01B | 545.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.613B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $179.908B | 74.58 |
| Thermo Fisher Scientific (TMO) | United States | $176.180B | 21.32 |
| Alcon (ALC) | Switzerland | $45.487B | 30.74 |
| Edwards Lifesciences (EW) | United States | $45.115B | 29.58 |
| IDEXX Laboratories (IDXX) | United States | $43.483B | 49.97 |
| DexCom (DXCM) | United States | $33.890B | 52.38 |
| IQVIA Holdings (IQV) | United States | $33.021B | 18.66 |
| Mettler-Toledo (MTD) | United States | $26.128B | 31.07 |
| STERIS (STE) | Ireland | $22.180B | 24.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.745B | 0.00 |
| Waters (WAT) | United States | $17.593B | 24.82 |
| Hologic (HOLX) | United States | $14.697B | 15.97 |
| Sysmex ADR (SSMXY) | Japan | $10.821B | 30.70 |
| Penumbra (PEN) | United States | $9.038B | 70.94 |
| Masimo (MASI) | United States | $8.946B | 33.00 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.485B | 0.00 |
| Teleflex (TFX) | United States | $5.181B | 8.55 |
| Integer Holdings (ITGR) | United States | $4.039B | 21.17 |
| TransMedics (TMDX) | United States | $3.720B | 80.86 |
| PROCEPT BioRobotics (PRCT) | United States | $3.323B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.406B | 14.32 |
| Nihon Kohden (NHNKY) | Japan | $2.154B | 24.71 |
| Elekta AB (EKTAY) | Sweden | $1.952B | 17.55 |
| Veracyte (VCYT) | United States | $1.896B | 26.60 |
| Alphatec Holdings (ATEC) | United States | $1.583B | 0.00 |
| Artivion (AORT) | United States | $1.334B | 124.96 |
| OPKO Health (OPK) | United States | $1.134B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.076B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.995B | 5.29 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| IRadimed (IRMD) | United States | $0.725B | 36.77 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Semler Scientific (SMLR) | United States | $0.542B | 11.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.411B | 9.54 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.382B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.324B | 0.00 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.244B | 14.76 |
| CVRx (CVRX) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.205B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.54 |